DPT Laboratories, a contract development and manufacturing organization specializing in semi-solid and liquid dosage forms, and Confab, a DPT company specializing in complex solids, semi-solids and liquids, have completed a combined $10 million capital investment.

San Antonio-based DPT has invested in a new compounding suite and significant upgrades to production filling lines that will increase capacity, throughput and precision. Additional upgrades include a remodeled front office area and enhanced security to further restrict access to the manufacturing floor and further enhance GMP compliance.

Confab, based in Montreal, made a significant investment to increase R&D capabilities with a new laboratory, new equipment and expansion of its R&D team. Confab can now offer customers pharmaceutical development capabilities ranging from formulation development and analytical method development to technology transfers at commercial scale.

Source: DPT Laboratories